Introducing Fluidity One-W Serum
Sign up for our latest webinar
Our company vision
Our latest application note
The technology underlying our instruments has been featured in a number of high impact, peer-reviewed journals.
Our technology reveals the differences in the antibody affinity and stoichiometry for four clinical stage anti-Aβ drug candidates to treat Alzheimer’s Disease
Clinical researchers discover the spectrum of antibody affinity from plasma of COVID-patients using our technology
Microfluidic diffusional sizing helps elucidate the specificity and selectivity of designed antibodies against Aβ oligomers